Patrys Limited

ASX (AUD): Patrys Limited (PAB)

Last Price

0.004

Today's Change

+0.001 (33.33%)

Day's Change

0.004 - 0.004

Trading Volume

16,898,282

Overview

Market Cap

8 Million

Shares Outstanding

2 Billion

Avg Volume

1,513,066

Avg Price (50 Days)

0.00

Avg Price (200 Days)

0.01

PE Ratio

0.00

EPS

0.00

Earnings Announcement

21-Feb-2025

Previous Close

0.00

Open

0.00

Day's Range

0.004 - 0.004

Year Range

0.003 - 0.01

Trading Volume

16,898,282

Price Change Highlight

1 Day Change

33.33%

5 Day Change

0.00%

1 Month Change

33.33%

3 Month Change

-33.33%

6 Month Change

-55.56%

Ytd Change

-50.00%

1 Year Change

-50.00%

3 Year Change

-89.47%

5 Year Change

-78.95%

10 Year Change

-75.62%

Max Change

-99.30%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates cell nuclei. The company also focuses on developing PAT-DX1, an antibody fragment for the treatment of primary and secondary brain cancer. In addition, it is developing PAT-DX3, a full-sized antibody that has DNA-binding and DNA damage repair blocking properties of PAT-DX1 used for tissue distribution, pharmacokinetic profile, etc.; and PAT-DX1-NP, a product based on the targeted delivery of nanoparticles carrying therapeutic payloads to the inside of cancer cells. The company was incorporated in 2006 and is based in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment